@Oldpa1
Cardiol (TSX CRDL)
CBD treatment for inflammation related heart disease from Cardiol
Cardiol Therapeutics Announces Formation of Data Safety Monitoring and Clinical Endpoint Committees for Phase II/III Outcomes Trial in High-Risk Patients Hospitalized with COVID-19 - Investing News Network
investigating other inflammation related disease treatments
(linked in as well for those interested)
Looking forward to the company making news flow here
GLA